Exhibitor Information
AAPath is excited to welcome back LIVE exhibits to our 2025 Annual Meeting! Continue reading for more information about exhibit and sponsorship opportunities for the 2025 meeting. Applications are accepted until SOLD OUT or 6/15/2025. Please contact [email protected] for any questions.
The exhibitor prospectus contains information about who attends the AAPath Annual Meetings, exhibit and sponsorship opportunities, and how to apply. Below is a quick look at the exhibit and sponsorship opportunities still available.
Exhibitor Level Specifications
- 5 Gold Exhibitors - $5,000 SOLD OUT as of 4/11/25
- 14 Silver Exhibitors - $4,000 3 Silver Levels left as of 6/6/25
- 5 Non-Profit Exhibitors - $3,500 2 Non-Profit Levels left as of 6/6/25
Additional Sponsorship Opportunities
- Meeting Room Drop – $750 per piece
- Branded Lanyards – $3,000 (Only 1 Available) SOLD OUT as of 1/24/25
- Additional Exhibitor Meeting Registration – $1,295 per registration
- Virtual Corporate Workshop – $3,000 per workshop
Thank You to AAPath’s 2025 Sponsors and Exhibitors As of May!
American Board of Pathology (ABPath) – The ABPath is the premier organization for certification and Continuing Certification (CC), of physicians in the specialty of pathology. Our mission is to serve the public and advance the profession of pathology by setting certification standards and promoting lifelong competency of pathologists. The ABPath offers certification Anatomic and/or Clinical Pathology and in 11 subspecialties.
American Registry of Pathology (ARP) – American Registry of Pathology is dedicated to its mission to advance, educate, and connect the field of pathology. A cornerstone of ARP's commitment is the publication of the renowned AFIP Fascicles. These comprehensive atlases of tumor and non-tumor pathology have been a trusted resource for tens of thousands of pathologists and institutions across the globe for over seven decades.
American Society for Clinical Pathology (ASCP) – With more than 100,000 members, including board-certified anatomic and clinical pathologists, pathology residents and fellows, laboratory professionals, and students around the world, we represent, champion, and advocate for all persons in the laboratory, and the patients they care for. ASCP pursues excellence, growth, and education in pathology and laboratory medicine, and we continually push ourselves forward to better understand how we can share our knowledge with the healthcare community to provide high-quality care for all.
Amgen – Amgen Oncology is advancing all angles of care. Through ourmission and our medicines, we’re transforming what’s possible.
AstraZeneca – AstraZeneca is a global, science-led, patient-focused pharmaceutical company. AstraZeneca’s Precision Medicine Team’s mission is to help you navigate the ever-expanding landscape of precision medicine. We’re committed to helping you identify the right patients appropriate for biomarker testing to help ensure they receive the right treatment at the right time.
Biocartis – Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary Idylla platform. The Idylla platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in virtually any setting. With Idylla, labs can produce molecular oncology testing results within 90 – 180 minutes and only 2 minutes hands-on-time directly from FFPE tissue.
Caris Life Sciences – Caris Life Sciences® is a leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Caris has created the large-scale, multi-modal database and computing capability needed to analyze and unravel the molecular complexity of disease. CarisLifeSciences.com.
Coronis Health – Coronis Health is a leading provider of revenue cycle management (RCM) solutions for physician specialties, hospitals, and health systems nationwide. Guided by a commitment to innovation, integrity, and empathy, we combine cutting-edge technology, actionable analytics, and deep industry expertise to simplify RCM complexities and empower healthcare organizations to thrive.
Daiichi Sankyo, Inc. – Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development and delivery of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast, lung and gastric cancer, tenosynovial giant cell tumor and iron deficiency anemia.
Dolbey – Dolbey offers award-winning healthcare solutions that enhance productivity, deliver better documentation, and improve patient care. Dolbey’s leading solutions are Fusion Narrate, AI Assist, and Fusion Narrate Text. Fusion Narrate consistently receives the highest overall performance score within the Speech Recognition: Front-End EHR product category with component classification.
FUJIFILM Healthcare Americas Corporation – Accelerate your digital pathology transformation. Fujifilm’s vendor-agnostic Pathology PACS solution Synapse® Pathology streamlines case management through proprietary advances in image digitization and solution interoperability to accelerate pathology-report turnaround. The solution’s open, cloud-accessible architecture allows customers to select the instruments, AI tools, and systems required for their own pathology workflows and use cases, such as clinical diagnosis, research, tumor boards, etc.
Merck & Co., Inc. – At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.
MorgueBoard LLC – MorgueBoard® is a Software-as-a-Service (SaaS) platform facilitating comprehensive, real-time patient and decedent tracking from death through final disposition.
Recordati Rare Diseases Inc – Recordati is uniquely structured to bring treatment options across specialty and primary care, consumer healthcare, and rare diseases. We have fully integrated operations across research & development, chemical and finished product manufacturing through to commercialization and licensing. We are continually growing, with a focus on developing new specialties, new treatments and investing in medical innovations that bring a brighter future to patients across the world.
Roche Diagnostics – Roche provides innovative diagnostic solutions to increase productivity in pathology labs and to help healthcare providers make faster, more confident decisions. Our portfolio includes automated slide staining and state of the art sample tracking, a broad menu of diagnostic assays, and digital pathology solutions. We partner with our customers to improve workflow efficiency, deliver enhanced medical value, and ensure safety for both the user and the patient.
United States and Canadian Academy of Pathology – The United States and Canadian Academy of Pathology (USCAP) is dedicated to creating a better pathologist. It accomplishes this through its mission to provide the ultimate in continuing medical education and translational research to improve practices and patient outcomes globally. While global health through education is a strategic initiative, the diverse educational activities provided by USCAP ensure personalized education that will influence personalized medicine. Modern educational delivery methods using digital assets prepare pathologists for next generation learning and make possible outreach to colleagues working in low-resource countries. As a member organization, USCAP is dedicated to providing solutions and creating members for life, including PhD colleagues.
Thank You to AAPath’s 2024 Sponsors and Exhibitors!

Questions?
Exhibitors, sponsors, and related inquiries should contact [email protected] or call 302-660-4943.
|